Oct 30 2024 28 mins 3
Welcome back Rounds Table Listeners!
We are back today with a special Rapid Fire Podcast!
This week, Drs. Mike Fralick and Justin Boyle discuss top papers from the 2024 European of Society of Cardiology Congress. Here we go!
- Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease (0:00 – 9:25).
- Beta-Blocker Interruption or Continuation after Myocardial Infarction (9:25 – 13:52).
- Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (13:52 – 21:20).
- Continuation vs. Discontinuation of Renin-Angiotensin System Inhibitors Before Major Non-Cardiac Surgery (21:20 – 28:51).
Of note, for prescribers in Ontario, there is now a limited use code for finerenone for patients that have both T2DM and CKD.
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
